Market Cap 29.44M
Revenue (ttm) 520,000.00
Net Income (ttm) -16.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,194.23%
Debt to Equity Ratio 0.00
Volume 3,700
Avg Vol 8,236
Day's Range N/A - N/A
Shares Out 11.46M
Stochastic %K 3%
Beta 1.32
Analysts Strong Sell
Price Target $12.50

Latest News on CLGN

CollPlant Biotechnologies Provides a Corporate Update

Feb 12, 2025, 6:00 AM EST - 7 weeks ago

CollPlant Biotechnologies Provides a Corporate Update


CollPlant Issues Letter to Shareholders

Feb 15, 2024, 8:00 AM EST - 1 year ago

CollPlant Issues Letter to Shareholders


CollPlant: Expanding End-Market Opportunities

Feb 12, 2023, 6:31 AM EST - 2 years ago

CollPlant: Expanding End-Market Opportunities